Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020
About Chronic Obstructive Pulmonary Disease (COPD)
COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema.
Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The
condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the
walls of the alveoli, resulting in difficulty in breathing.
Publisher's analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a
CAGR of 4.85% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary
disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue
generated from the sales of branded, generic, and off-label drugs used to treat COPD.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
View Complete Report @ http://www.reportsweb.com/global-chronic-obstructive-pulmonary-
disease-drugs-market-2016-2020
Contact Us : +91-20-67278686 | E-Mail : [email protected]